- Lori Slattery
Our monthly tumor board conference promotes dissemination of information regarding the most current and/or proven therapies related to the diagnosis, treatment, and monitoring of patients with cancer. The forum provides a multidisciplinary case-based discussion with the goal of developing individualized patient treatment plans and options while protecting patient confidentiality. The discussion provides for an enhancement of competency when evaluating patients diagnosed with cancer.
Our target audience includes physicians and APPs from the following areas: general and internal medicine, medical oncology, palliative care, general surgery, radiology, radiation oncology, and pathology. Other professionals include clinical research staff, RNs, pharmacy staff, social work, prior authorization, administration, radiation planning, and administrative guests.
|Ron Kirschling, MD, Chair||Mary Merdan, NP||Lori Slattery, RN, BSN, MASL, Coordinator|
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 ANCC contact hour.
The University of Wisconsin–Madison School of Nursing is Iowa Board of Nursing provider 350.
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison ICEP, that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s).
Detailed disclosures will be available prior to the start of the activity.
After attending sessions:
- Attendees will increase their medical knowledge of oncologic conditions and their treatment.
- Attendees will report enhanced inter-professional communication and awareness of roles/responsibilities of the management of cancer patients.